Cognios Capital’s Boston Scientific BSX Stock Holding History

Cognios Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-28,460	Closed	-$928K	–	40
2020 Q1	$928K	Sell	28,460 -2,416	-8%	-$94.4K	0.46%	99
2019 Q4	$1.4M	Buy	+30,876	New	+$1.29M	0.49%	101

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cognios Capital's BSX Position: Q2 2020 in Review

Cognios Capital sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 28,460 shares — an estimated $928K sold.

Cognios Capital first reported a position in BSX in Q4 2019 and held it in 2 quarters. The position peaked at $1.4M in Q4 2019. 841 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

Cognios Capital reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
Cognios Capital sold 28,460 Boston Scientific shares in Q2 2020, an estimated $928K.
Cognios Capital first reported a position in Boston Scientific in Q4 2019 and held it in 2 quarters.
Cognios Capital's Boston Scientific position peaked at $1.4M in Q4 2019.
841 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.